FDA Warning Letter — Summit Research

Case 695607 — FEI 3032615861

The FDA took a Warning Letter action against Summit Research on Dec 10, 2024 (Hoover, AL). The action was issued by CDER and concerns drugs products.

Action Details

Facility
Summit Research
Date
Dec 10, 2024
Fiscal Year
2025
Product Type
Drugs
Center
CDER
Location
Hoover, AL (United States)